CHARLOTTE, N.C., July 9 USHIFU, LLC, a global leader innon invasive high intensity focused ultrasound (HIFU) technology, is proud toannounce sponsorship of the Sonablate(R) International HIFU Registry ...

CHARLOTTE, NC / ACCESSWIRE / July 6, 2018 / A 5-year multicenter study following focal therapy for prostate cancer, with the Sonablate HIFU technology, has been published and shows it is possible to ...

SonaCare Medical has reported five-year outcomes from a study of focal therapy using its Sonablate high-intensity focused ultrasound (HIFU) system. The multicentre study included 625 patients with ...

Los Angeles-based miVIP Surgery Centers is the first in Southern California to offer outpatient treatment with Sonablate for prostate cancer. 1. Sonablate is designed to provide high intensity focused ...

CHARLOTTE, N.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sonablate Corp., current makers of the Sonablate HIFU system for prostate tissue ablation, today announced the first patient enrolled in the HIFIVE U ...

CHARLOTTE, NC, UNITED STATES, June 21, 2023/EINPresswire.com/ -- Sonablate Corp., a global leader in minimally invasive focused ultrasound technologies, today ...

Aug. 23, 2005 — The European Commission has approved a bare metal vascular stent with a bioengineered coating that promotes rapid and controlled healing at the lesion site and a biodegradable implant ...

This is a companion article to Ultrasound’s war on prostate cancer, which was published in the July 2011 issue of Test & Measurement World. For companies who make medical devices, the path to FDA ...

CEDAR RAPIDS, Iowa — Mercy Medical Center has introduced a new non-invasive treatment for men with localized prostate cancer called Sonablate. This focal therapy uses high-intensity focused ultrasound ...

The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined ...

(MENAFN- ein presswire) by introducing sonablate hifu to our range of treatments, we can provide patients with a highly targeted, minimally invasive alternative.” - dr. bertram lewischarlotte, nc, ...

HIFIVE is a single arm, single institution, Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins including vascular ...